announces

Mayilaa — A Newton Cinema Production — Announces World Premiere at the 55th International Film Festival Rotterdam (IFFR)

ROTTERDAM, Netherlands, Jan. 29, 2026 /PRNewswire/ -- Newton Cinema announces that its feature film Mayilaa has been officially selected for…

3 weeks ago

Womens Health Collective Canada Announces Vital Talks Event on Menstruation and Lifelong Hormonal Health, Presented by Vichy Laboratoires

TORONTO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada is pleased to announce the second installment of Vital Talks,…

3 weeks ago

Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage

SAN FRANCISCO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced…

3 weeks ago

Springer Nature Announces Leadership Transition in India

Arend Kuester joins as India Country Manager, to be based in Pune, and will lead the Research business for the…

3 weeks ago

Wix Announces Board Authorization of $2 Billion Share Repurchase Program

Wix.com Ltd. (NASDAQ: WIX) ("Wix," the "Company," "we" or "our"), today announced that its Board of Directors (the "Board") authorized…

3 weeks ago

Guidepoint India Announces Strategic Expansion of its Mumbai Office

MUMBAI, India, Jan. 27, 2026 /PRNewswire/ -- Guidepoint India today announced the strategic relocation and expansion of its Mumbai Office,…

3 weeks ago

Dubai announces largest demand-led expansion of a financial centre in the Middle East, Africa and South Asia – with a total gross floor area of 17.7mn sq.ft.

DUBAI, UAE, Jan. 27, 2026 /PRNewswire/ -- His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister…

3 weeks ago

AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering

OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the…

3 weeks ago

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural…

3 weeks ago

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

January 23, 2026 17:00 ET  | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) --…

3 weeks ago